You are here

Article Text

Article menu
Download PDFPDF
Original article
Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis
  1. Suhair Jabbar1,
  2. John Drury2,
  3. John N Fordham1,
  4. Harish K Datta3,
  5. Roger M Francis4,
  6. Stephen P Tuck1
  1. 1Rheumatology Department, The James Cook University Hospital, Middlesbrough, UK
  2. 2Pathology Department, The James Cook University Hospital, Middlesbrough, UK
  3. 3Department of Clinical Biochemistry, Newcastle University, Newcastle upon Tyne, UK
  4. 4The Institute of Ageing and Health, Newcastle University, Campus of Ageing and Vitality, Newcastle upon Tyne
  1. Correspondence to Dr SP Tuck, Department of Rheumatology, James Cook University Hospital, Marton Road, Middlesbrough TS4 3BW, UK; stephen.tuck{at}stees.nhs.uk

Abstract

Background Osteoprotegerin (OPG) and receptor activator of nuclear factor κ B ligand (RANKL) play a critical role in the regulation of bone turnover, but the relative importance of these two cytokines in the pathogenesis of postmenopausal osteoporosis is controversial.

Aim To investigate the relationship between circulating levels of OPG, RANKL, bone turnover and bone mineral density (BMD) in postmenopausal women.

Methods A cross-sectional study of 185 women with osteoporosis and 185 age- and sex-matched control subjects was undertaken. Measurements were made of plasma OPG, RANKL, interleukin-6 (IL-6), sex steroids, calciotropic hormones, biochemical markers of bone turnover, BMD and anthropometry. Health questionnaires were administered.

Results Plasma RANKL was significantly higher (p<0.0001) in women with osteoporosis (0.66±0.67 pmol/l) than in control subjects (0.37±0.38 pmol/l), as was plasma OPG (18.70±9.70 pmol/l in women with osteoporosis, 10.44±5.85 pmol/l in control subjects; p<0.0001). OPG/RANKL ratio was higher in women with osteoporosis (51.3) than in control subjects (36.6). The women with osteoporosis also had significantly higher biochemical markers of bone turnover, IL-6 and parathyroid hormone and lower 25-hydroxyvitamin D and oestradiol than the control subjects. Multiple regression analysis showed that lumbar spine and femoral neck BMD in postmenopausal women were best predicted by OPG and RANKL, giving an R2 value of 15.5% and 14.9%, respectively.

Conclusions This study indicates that the circulating levels of OPG and RANKL are inversely related to BMD and contribute to the development of osteoporosis in postmenopausal women.

  • Bone mineral density
  • osteoporosis
  • RANKL
  • RANK
  • osteoprotegerin
  • ageing
  • bone
  • bone cells
  • bone pathology
  • rheumatological pathology

https://doi.org/10.1136/jcp.2010.086595

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests None.

    • Ethics approval This study was conducted with the approval of the South Tees Ethics Committee.

    • Provenance and peer review Not commissioned; externally peer reviewed.